These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35366783)
1. The Effect of Aspirin on the Prevention of Pro-thrombotic States in Hospitalized COVID-19 Patients: Systematic Review. Abdi M; Lamardi ZH; Shirjan F; Mohammadi L; Abadi SSD; Massoudi N; Zangiabadian M; Nasiri MJ Cardiovasc Hematol Agents Med Chem; 2022; 20(3):189-196. PubMed ID: 35366783 [TBL] [Abstract][Full Text] [Related]
2. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
3. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19. Haji Aghajani M; Moradi O; Amini H; Azhdari Tehrani H; Pourheidar E; Rabiei MM; Sistanizad M J Med Virol; 2021 Sep; 93(9):5390-5395. PubMed ID: 33913549 [TBL] [Abstract][Full Text] [Related]
4. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial. Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910 [TBL] [Abstract][Full Text] [Related]
5. Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Cacciapuoti F; Cacciapuoti F Clin Appl Thromb Hemost; 2021; 27():10760296211014592. PubMed ID: 33928791 [TBL] [Abstract][Full Text] [Related]
6. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Schrör K Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351 [TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors. Coccheri S Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498 [TBL] [Abstract][Full Text] [Related]
8. Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19. Sahai A; Bhandari R; Godwin M; McIntyre T; Chung MK; Iskandar JP; Kamran H; Hariri E; Aggarwal A; Burton R; Kalra A; Bartholomew JR; McCrae KR; Elbadawi A; Bena J; Svensson LG; Kapadia S; Cameron SJ Vasc Med; 2021 Dec; 26(6):626-632. PubMed ID: 34010070 [TBL] [Abstract][Full Text] [Related]
9. Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism. Haque S; Jawed A; Akhter N; Dar SA; Khan F; Mandal RK; Areeshi MY; Lohani M; Wahid M Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9244-9245. PubMed ID: 33015764 [No Abstract] [Full Text] [Related]
10. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty. Byrne A; Moran N; Maher M; Walsh N; Crean P; Fitzgerald DJ Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3224-9. PubMed ID: 9409315 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
17. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis. Mainoli B; Duarte GS; Costa J; Ferreira J; Caldeira D Am J Cardiovasc Drugs; 2021 Jan; 21(1):63-71. PubMed ID: 32394295 [TBL] [Abstract][Full Text] [Related]
18. [The effect of antiplatelet therapy on the course of COVID-19]. Edilgireeva LA; Sadulaeva TA; Zakharov VV; Vakhnina NV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):16-21. PubMed ID: 35394714 [TBL] [Abstract][Full Text] [Related]
19. A critical appraisal of the phenomenon of aspirin resistance. Svenstrup Poulsen T; Kristensen SR; Atar D; Mickley H Cardiology; 2005; 104(2):83-91. PubMed ID: 16020925 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy and anticoagulation in patients with hypertension. Griffin G Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]